Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,411 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

NCT06035497

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
Locations
  • Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
  • Local Institution - 0011 Nagoya, Aichi-ken, Japan
  • Local Institution - 0024 Toyohashi, Aichi-ken, Japan
  • Local Institution - 0017 Kamogawa, Chiba, Japan
View all 40 locations
View Trial Details
Active, Not Recruiting

Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

NCT04608318

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • LKH-Universtitätsklinikum Graz Graz, Austria
  • Landeskrankenhaus - Universitätskliniken Innsbruck Innsbruck, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Hanusch Krankenhaus Vienna, Austria
View all 181 locations
View Trial Details
Active, Not Recruiting

Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT02890329

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission

NCT05413018

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Local Institution - 0031 Hefei, Anhui, China
  • Local Institution - 0013 Beijing, BJ, China
  • Local Institution - 0027 Beijing, BJ, China
  • Local Institution - 0028 Chongqing, CQ, China
View all 34 locations
View Trial Details
Active, Not Recruiting

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT04898894

Conditions
Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +14 more
Locations
  • Rady Children's Hospital-San Diego San Diego, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

DS-3201b in Participants With Lymphomas

NCT02732275

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope National Medical center Duarte, California, United States
  • Yale University New Haven, Connecticut, United States
  • Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

NCT01627041

Conditions
Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia, +17 more
Locations
  • Lafayette Family Cancer Center-EMMC Brewer, Maine, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions